Once daily formulations of tetracyclines
CA 2803922 C · Owner: Supernus Pharmaceuticals, Inc. · Inventors: Shah, Niraj; Raoufinia, Arash; Chang, Rong-Kun
Overview
Its claims, description and drawings are in the Canadian Patents Database.
Open the CIPO recordAbstract From the Canadian patent
Disclosed are once-daily formulations containing tetracyclines especially doxycycline. Such formulations are useful for instance, for the treatment of collagenase destructive enzyme-dependent diseases such as periodontal disease and acne, and acute and chronic inflammatory disease states such as rosacea and arthritis.
Read the whole patent
Listed from its CIPO record in Patent Yard's archive of Canadian patents past their term. Its claims, description and drawings are in the CIPO record and on Google Patents, and the Claude kit works from them.
Why it's free to use
- Filed April 7, 2004 and granted September 15, 2015. A Canadian patent filed from October 1, 1989 lasts 20 years from filing, so its term ended April 7, 2024.
- A certificate of supplementary protection adds at most two years for a drug, so even that would have ended by April 7, 2026.
- We check Canadian rights only. A patent in its family in another country could still be in force: check its family on Google Patents.
Timeline
Timeline From CIPO dates
Sources & verification
Official CIPO records
Everything on this page comes from the CIPO record linked above. Contains information licensed under the Open Government Licence – Canada.